Method for monitoring medication based on renal function level of patient

Abstract

The invention discloses a method for monitoring medication based on the renal function level of a patient. The method comprises the following steps: S1, creating a monitored medicament directory, and setting a monitoring creatinine clearance rate value and a corresponding recommended medicament dose, a dosing frequency or a forbidden identifier; S2, acquiring basic information and checking information of the patient, including information of the gender, the age, the height and the serum creatinine value; S3, calculating the creatinine clearance rate of the patient according to the acquired checking information of the patient; S4, judging whether a medicament order of a doctor belongs to medicaments in the range of the monitored medicament directory or not; and S5, when the medicament order of the doctor belongs to the medicaments in the range of the monitored medicament directory, prompting the doctor according to the calculated creatinine clearance rate, recording the creatinine clearance rate and identifying medication information of the patient. Through adoption of the method, the problems of low manual intervention efficiency and incapability of prompting immediately at present are solved, and the timeliness and security of clinical medication are ensured. Moreover, the method has a pre-prompting function, an in-process monitoring function, and a post statistical analysis function.

Description

technical field [0001] The invention belongs to the field of medicine monitoring, and in particular relates to a method for monitoring medicine based on a patient's renal function level. Background technique [0002] Studies at home and abroad have shown that there are risks in the safety of medication for patients with renal insufficiency. It has been reported in the literature that 77.3% of patients with renal insufficiency use antibiotics unreasonably, and studies have shown that 89% of patients with renal insufficiency have chosen at least one drug that contradicts their renal insufficiency or the wrong dosage during hospitalization . Based on the medication survey of patients with renal insufficiency in our hospital in 2015, it was also shown that 52.8% of patients with renal insufficiency had medication risks. [0003] There are currently two methods for drug monitoring in patients with renal insufficiency: Pharmacists participate in daily ward rounds and manual do...

AI Technical Summary

Problems solved by technology

Based on the drug survey of patients with renal insufficiency in our hospital in 2015, it was also shown that 52.8% of patients with renal insufficiency had medication risks.

[0003] There are currently two methods for drug monitoring in patients with renal insufficiency: Pharmacists participate in daily ward rounds and manual doctor's order review, and intervene in patients' medication; Use the intelligent medication monitoring system to review the rationality of clinical doctor's prescription medication, and give risk reminders if it is unreasonable

These two methods have achieved certain results, but there are still the following problems: my country's clinical pharmacists are seriously understaffed relative to hospital beds, and the efficiency of manual intervention in doctor's orders is low, which cannot fundamentally solve the requirements of timeliness and safety of clinical medication; The rational drug use monitoring system in most hospitals in China can only review the relationship between drugs, such as primary reminders such as drug interactions and incompatibility, and cannot be combined with specific test values ​​and clinical conditions of patients

Therefore, in practical applications, the warning information that appears does not necessarily match the actual situation of the patient, causing warning fatigue to doctors, and ignoring important warnings when issuing medical orders, resulting in the occurrence of adverse drug events

Images